BRIDGEBIO PHARMA INC (BBIO:NASDAQ)
$66.64 -1.36 (-2%)
Analysed BRIDGEBIO PHARMA INC (BBIO:NASDAQ) News Sources
How Encaleret’s NDA and New Acoramidis Milestones Could Reframe BridgeBio Pharma (BBIO) Investors’ Outlook
15-05-2026
yahoo.com
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
19-05-2026
yahoo.com
Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn’t a Slam Dunk
19-05-2026
247wallst.com
Intel downgraded, Marvell upgraded: Wall Street's top analyst calls
26-05-2026
yahoo.com
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
27-05-2026
yahoo.com
Allogene CEO to step down; Agios drug fails key test
29-05-2026
biopharmadive.com
Does FDA Priority Review for First LGMD Therapy Change The Bull Case For BridgeBio Pharma (BBIO)?
01-06-2026
yahoo.com
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls
03-06-2026
yahoo.com
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boyd Gaming, Chipotle Mexican Grill, Conagra, Dollar General, MGM Resorts International, Omnicom Group, Yum! Brands, and More
03-06-2026
247wallst.com
DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific Markets
11-06-2026
yahoo.com
What is the current price of BRIDGEBIO PHARMA INC (BBIO:NASDAQ)?
The current price of BRIDGEBIO PHARMA INC (BBIO:NASDAQ) is $66.64.
BRIDGEBIO PHARMA INC (BBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of BRIDGEBIO PHARMA INC (BBIO:NASDAQ) since the previous trading day is $-1.36.
BRIDGEBIO PHARMA INC (BBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of BRIDGEBIO PHARMA INC (BBIO:NASDAQ) since the previous trading day is -2%.
What is the most recent average sentiment score for BRIDGEBIO PHARMA INC (BBIO:NASDAQ)?
The most recent average sentiment score for BRIDGEBIO PHARMA INC (BBIO:NASDAQ) is 45 out of 100.
What is the most recent average sentiment for BRIDGEBIO PHARMA INC (BBIO:NASDAQ)?
The most recent sentiment for BRIDGEBIO PHARMA INC (BBIO:NASDAQ) is .
SEC-8K** Filing Available For BRIDGEBIO PHARMA INC (BBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.